Sharon Bakalash

Dr. Bakalash is a seasoned biotechnology entrepreneur and an ophthalmic surgeon with more than two decades of demonstrated leadership in Business, science, and medicine. Before stepping in as TissueGen’s CEO, she headed several biotechnology companies in the ophthalmic space (dSentz, OphRx) and is the founder of SB Strategic Development Consultants Group, which provides clinical development, strategic planning, and business development guidance, where she has been working closely with start-up companies, venture funds and global pharma companies- spanning the pharmaceutical, drug delivery and surgical device arenas.

Dr. Bakalash holds an MD from Ben Gurion University, a PhD in Neuroimmunology from the Weizmann Institute of Science, and a Business degree from Northeastern University. Dr. Bakalash has also completed a post-doctoral fellowship at Harvard University.